or Try an Advanced Search...

    Hepatitis B Virus Stocks List

    Symbol Grade Name % Change
    NNVC A NanoViricides, Inc. 20.83
    ABUS B Arbutus Biopharma Corporation 0.00
    HOOK C HOOKIPA Pharma Inc. -3.26
    INO C Inovio Pharmaceuticals, Inc. -1.35
    NTLA F Intellia Therapeutics, Inc. -3.69
    IONS F Ionis Pharmaceuticals, Inc. -1.88
    VIR F Vir Biotechnology, Inc. -3.93
    BMY F Bristol-Myers Squibb Company -0.84
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Hepatitis B Immunodeficiency Infectious Diseases Hepatitis C Hepatitis C Virus Amyloid Amyloidosis Biopharmaceutical Biotechnology Cancer Coronavirus Influenza Medicine Alcohol Cholesterol Diabetes Dystrophy Ebola Genetics Hepatitis C Virus Infection

    Related ETFs - A few ETFs which own one or more of the above listed Hepatitis B Virus stocks.

    Symbol Grade Name Weight
    ARKG F ARK Genomic Revolution Multi-Sector ETF 8.55
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 7.16
    MEDX D Horizon Kinetics Medical ETF 5.43
    GNOM D Global X Genomics & Biotechnology ETF 4.89
    HELX D Franklin Genomic Advancements ETF 4.4
    View all Hepatitis B Virus ETFs...
    Compare ETFs
    Compare ARKG to FTXH Compare GNOM to HELX Compare MEDX to HELX

        Hepatitis B Virus Stocks Recent News

        Date Stock Title
        May 8 IONS Ionis Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        May 8 BMY Bristol-Myers Squibb Insiders Sell US$1.1m Of Stock, Possibly Signalling Caution
        May 8 NNVC A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
        May 8 VIR Analysts Just Shipped A Stunning Upgrade To Their Vir Biotechnology, Inc. (NASDAQ:VIR) Estimates
        May 8 IONS Q1 2024 Ionis Pharmaceuticals Inc Earnings Call
        May 8 IONS Ionis Pharmaceuticals Inc (IONS) Q1 2024 Earnings Call Transcript Highlights: Key Developments ...
        May 7 IONS Ionis Pharmaceuticals, Inc. (IONS) Q1 2024 Earnings Call Transcript
        May 7 BMY A Look at Pharma ETFs Post Q1 Earnings
        May 7 VIR Wall Street Analysts Think Vir Biotechnology (VIR) Could Surge 188.65%: Read This Before Placing a Bet
        May 7 IONS Ionis Pharmaceuticals (IONS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
        May 7 IONS Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Misses Revenue Estimates
        May 7 IONS Ionis Pharmaceuticals GAAP EPS of -$0.98 beats by $0.09, revenue of $119M misses by $17.41M
        May 7 IONS Ionis reports first quarter 2024 financial results
        May 6 BMY FDA accepts Bristol Myers application for injected Opdivo
        May 6 IONS Ionis Pharmaceuticals Q1 2024 Earnings Preview
        May 6 IONS Wall Street's Insights Into Key Metrics Ahead of Ionis Pharmaceuticals (IONS) Q1 Earnings
        May 6 BMY U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
        May 6 BMY European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite...
        May 6 NNVC A Novel Broad-Spectrum Antiviral with Activity Against Influenza A
        May 5 INO This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Hepatitis B Immunodeficiency Infectious Diseases Hepatitis C Hepatitis C Virus Amyloid Amyloidosis Biopharmaceutical Biotechnology Cancer Coronavirus Influenza Medicine Alcohol Cholesterol Diabetes Dystrophy Ebola Genetics Hepatitis C Virus Infection
        Hepatitis B Virus

        Hepatitis B virus (HBV), is a partially double-stranded DNA virus, a species of the genus Orthohepadnavirus and a member of the Hepadnaviridae family of viruses. This virus causes the disease hepatitis B.

        More about Hepatitis B Virus
        Browse All Tags